Eden Aesthetics has announced the expansion of its JetPeel range with the introduction of JetCare Med, a new collection of advanced transdermal infusions designed for professional, in-clinic use. The launch marks a significant development for the JetPeel brand, which is known for its needle-free technology that delivers active ingredients deep into the skin without discomfort or downtime.
JetCare Med is a specialized series of five formulations enriched with over 5.5% osmolytes, which are small organic compounds that help maintain cell hydration and protein stability. These new infusions aim to enhance the visible effects of JetPeel treatments by targeting specific skin concerns, including fine lines, uneven texture, dullness, and loss of firmness.
Each treatment is delivered through JetPeel’s dedicated MDJet handpiece using pre-filled 5ml syringes, allowing for a streamlined application process during clinical procedures.
The JetCare Med lineup includes four targeted treatments and one booster:
JetCare Med Refill: A skin-smoothing infusion aimed at reducing fine lines and enhancing collagen for a firmer, more even skin tone.
JetCare Med Relax: Focused on muscle relaxation and hydration, this treatment supports a youthful, rested appearance.
JetCare Med Revitalize: Designed for mature skin, it contains peptides and anti-ageing ingredients to promote regeneration and skin resilience.
JetCare Med Relight: A brightening infusion rich in vitamin C, formulated to reduce dullness and protect against environmental stressors.
JetCare Med Refine Boost: Used as the final step, this booster enhances radiance and gives skin a lifted, glowing finish.
The JetCare Med formulations include a variety of active ingredients such as:
Osmolytes – To promote hydration and protein stability
Betaine – A plant-derived humectant to reinforce the skin barrier
Xylitol – A prebiotic agent that supports the skin’s microbiome
Inositol – Helps energize skin cells and improve elasticity
Propanediol – A natural hydrating glycol known for its soothing properties
According to Eden Aesthetics, a clinical study involving participants who received three JetCare Med treatments over eight days reported notable improvements eight weeks after treatment:
26% increase in skin density
16% increase in firmness
12% increase in elasticity
The treatments were reported to be well-tolerated across all skin types, including sensitive skin, with statistically significant results.
“As one of the early adopters of JetPeel in the UK, I see JetCare Med as a great evolution of the
platform. The new MDJet handpiece and pre-filled syringes streamline delivery, and independent
data demonstrates significant improvement in skin elasticity, firmness and dermal density within four
weeks, with no adverse reaction reported. I look forward to adding this innovation into my practice.” - Dr Nisha Menon
“We’re excited to offer JetCare Med to our practitioners as an extension of the JetPeel range. The range of infusions allows practitioners to target specific skin concerns, while also containing over 5.5% osmolytes to invigorate collagen and elastin. The clinical trial results show an increase in collagen and elastin, not only
immediately after treatment, but also continued improvements at 8 weeks.” - Lindsay Gray, Managing Director of Eden Aesthetics
The launch of the JetCare Med collection represents a step forward in customizable, non-invasive skincare treatments within the clinical setting. With its combination of targeted formulations and clinically-backed outcomes, JetCare Med is positioned to complement JetPeel’s existing offerings while addressing a wider range of patient needs.
As the demand for needle-free, effective aesthetic solutions continues to grow, this addition may offer clinics a new avenue for delivering visible results with minimal disruption to clients’ routines.